<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font18 { font-size : 18; } .font20 { font-size : 20; } .font23 { font-size : 23; } .font10 { font-size : 10; } .font11 { font-size : 11; } .font12 { font-size : 12; } .font13 { font-size : 13; } .font30 { font-size : 30; } .font14 { font-size : 14; } .font15 { font-size : 15; }</style>
 <body>
  <p>
   <span class="font30">and </span>
   <span class="font23">the </span>
   <span class="font20">with </span>
   <span class="font18">patients </span>
   <span class="font15">was </span>
   <span class="font15">mitochondrial </span>
   <span class="font14">therapy </span>
   <span class="font14">were </span>
   <span class="font14">for </span>
   <span class="font13">receiving </span>
   <span class="font13">Group </span>
   <span class="font13">{background </span>
   <span class="font13">The </span>
   <span class="font13">levels </span>
   <span class="font12">compared </span>
   <span class="font12">HBV </span>
   <span class="font12">DNA </span>
   <span class="font12">mtDNA </span>
   <span class="font12">(.%) </span>
   <span class="font12">duration </span>
   <span class="font12">antiviral </span>
   <span class="font12">margin </span>
   <span class="font12">significantly </span>
   <span class="font12">{border-style </span>
   <span class="font12">(–) </span>
   <span class="font12">not </span>
   <span class="font12">px;} </span>
   <span class="font12">study </span>
   <span class="font12">#ffffff;} </span>
   <span class="font12">been </span>
   <span class="font11">NAs </span>
   <span class="font11">from </span>
   <span class="font11">have </span>
   <span class="font11">showed </span>
   <span class="font11">treated </span>
   <span class="font11">BSC </span>
   <span class="font11">had </span>
   <span class="font11">ratio </span>
   <span class="font11">when </span>
   <span class="font11">entecavir </span>
   <span class="font11">infection </span>
   <span class="font11">tenofovir </span>
   <span class="font11">are </span>
   <span class="font11">associated </span>
   <span class="font11">clinical </span>
   <span class="font11">higher </span>
   <span class="font11">that </span>
   <span class="font11">toxicity </span>
   <span class="font11">(%) </span>
   <span class="font11">HBV-infected </span>
   <span class="font11">has </span>
   <span class="font11">lower </span>
   <span class="font11">those </span>
   <span class="font11">HIV </span>
   <span class="font11">N.LR </span>
   <span class="font11">also </span>
   <span class="font11">changes </span>
   <span class="font11">data </span>
   <span class="font11">hepatitis </span>
   <span class="font11">median </span>
   <span class="font11">mtRNA </span>
   <span class="font11">treatment </span>
   <span class="font11">(Group </span>
   <span class="font11">(p = .) </span>
   <span class="font11">(p = .). </span>
   <span class="font11">HIV-infected </span>
   <span class="font11">RNA </span>
   <span class="font11">but </span>
   <span class="font11">combination </span>
   <span class="font11">generation </span>
   <span class="font11">months </span>
   <span class="font11">negative </span>
   <span class="font11">(IQR </span>
   <span class="font11">between </span>
   <span class="font11">blood </span>
   <span class="font11">chronic </span>
   <span class="font11">found </span>
   <span class="font11">long-term </span>
   <span class="font11">mtDNA/nDNA </span>
   <span class="font11">mtRNA/nRNA </span>
   <span class="font11">significant </span>
   <span class="font11">total </span>
   <span class="font10">Patients </span>
   <span class="font10">analysis </span>
   <span class="font10">body </span>
   <span class="font10">current </span>
   <span class="font10">difference </span>
   <span class="font10">lamivudine </span>
   <span class="font10">lamivudine  adefovir </span>
   <span class="font10">may </span>
   <span class="font10">nucleoside </span>
   <span class="font10">our </span>
   <span class="font10">px; </span>
   <span class="font10">using </span>
   <span class="font10">{font-family </span>
   <span class="font10">(.–.) </span>
   <span class="font10">Mitochondrial </span>
   <span class="font10">cells </span>
   <span class="font10">fat </span>
   <span class="font10">font-size </span>
   <span class="font10">infected </span>
   <span class="font10">observed </span>
   <span class="font10">only </span>
   <span class="font10">patients, </span>
   <span class="font10">peripheral </span>
   <span class="font10">risk </span>
   <span class="font10">such </span>
   <span class="font10">this </span>
   <span class="font10">used </span>
   <span class="font10">which </span>
   <span class="font10">(months) </span>
   <span class="font10">CHB </span>
   <span class="font10">Furthermore, </span>
   <span class="font10">antiretroviral </span>
   <span class="font10">contributed </span>
   <span class="font10">controls </span>
   <span class="font10">correlation </span>
   <span class="font10">double; </span>
   <span class="font10">during </span>
   <span class="font10">effects </span>
   <span class="font10">impact </span>
   <span class="font10">lamivudine  adefovir, </span>
   <span class="font10">lipodystrophy </span>
   <span class="font10">reverse </span>
   <span class="font10">virus </span>
   <span class="font10">without </span>
   <span class="font10">(,%) </span>
   <span class="font10">(Fig. </span>
   <span class="font10">Hepatitis </span>
   <span class="font10">However, </span>
   <span class="font10">Tenofovir </span>
   <span class="font10">border-color </span>
   <span class="font10">border-width </span>
   <span class="font10">controls. </span>
   <span class="font10">currently </span>
   <span class="font10">entecavir, </span>
   <span class="font10">even </span>
   <span class="font10">exposed </span>
   <span class="font10">first </span>
   <span class="font10">human </span>
   <span class="font10">inhibitors </span>
   <span class="font10">lamivudine  adefovir. </span>
   <span class="font10">mononuclear </span>
   <span class="font10">monotherapy </span>
   <span class="font10">number </span>
   <span class="font10">other </span>
   <span class="font10">performed </span>
   <span class="font10">previously </span>
   <span class="font10">primer </span>
   <span class="font10">results </span>
   <span class="font10">shape </span>
   <span class="font10">signs </span>
   <span class="font10">solid; </span>
   <span class="font10">studies </span>
   <span class="font10">tenofovir, </span>
   <span class="font10">whereas </span>
   <span class="font10">{font-style </span>
   <span class="font10">{font-weight </span>
   <span class="font10">(p = .), </span>
   <span class="font10">APRI </span>
   <span class="font10">All </span>
   <span class="font10">Among </span>
   <span class="font10">Commons </span>
   <span class="font10">Creative </span>
   <span class="font10">Entecavir </span>
   <span class="font10">Figure </span>
   <span class="font10">Lamivudine </span>
   <span class="font10">NA-treated </span>
   <span class="font10">Our </span>
   <span class="font10">USA). </span>
   <span class="font10">after </span>
   <span class="font10">age, </span>
   <span class="font10">al.Mitochondrial </span>
   <span class="font10">alterations </span>
   <span class="font10">analogues </span>
   <span class="font10">bold </span>
   <span class="font10">both </span>
   <span class="font10">can </span>
   <span class="font10">cardiovascular </span>
   <span class="font10">correlated </span>
   <span class="font10">courier; </span>
   <span class="font10">drug </span>
   <span class="font10">duration. </span>
   <span class="font10">em; </span>
   <span class="font10">enrolled </span>
   <span class="font10">evaluate </span>
   <span class="font10">evidenced </span>
   <span class="font10">expression </span>
   <span class="font10">gene </span>
   <span class="font10">history </span>
   <span class="font10">known </span>
   <span class="font10">lactic </span>
   <span class="font10">lamivudine, </span>
   <span class="font10">patient </span>
   <span class="font10">patients. </span>
   <span class="font10">protease </span>
   <span class="font10">pt;} </span>
   <span class="font10">reactivation </span>
   <span class="font10">reported </span>
   <span class="font10">respect </span>
   <span class="font10">role </span>
   <span class="font10">statistical </span>
   <span class="font10">subjects </span>
   <span class="font10">suggest </span>
   <span class="font10">therapeutic </span>
   <span class="font10">values </span>
   <span class="font10">viral </span>
   <span class="font10">vitro </span>
  </p>
 </body>
</html>
